Skip to main content

Table 2 Reported cases of biochemically-hyperthyroid patients with a reported hyperfunctioning nodule discovered to harbor thyroid carcinoma on pathological review

From: A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature

#

Age

Sex

Tumor growth (cm)

High risk history a

Suspicious U/S b

Nodule size c(cm)

Tumor size d(cm)

TFTs e

Toxic sx?

Compression sx?

Scan type

FNA

Surgical path

Reference (1st author)

1

29

F

 

-

IV

2.7

2.5

SHT

+

-

123I

 

FTC

Current case

2

43

F

 

-

-

6.5

5

fT3,fT4

+

-

Tc

 

Hurthle

Karanchi [23]

3

13

F

 

-

IV

3.5

5

TT3

-

-

123I

 

Hurthle

Yalla [24]

4

63

M

 

-

-

4

 

fT4

-

-

123I

Suspicion of FVPTC

FVPTC

Bommireddipalli [25]

5

68

F

 

-

HE

5.3

 

fT3

+

+

Tc,123I

 

FTC

Giovanella [26]

6

11

F

 

-

-

3.5

 

TT3

-

-

123I

Nonspecific

PTC

Tfayli [27]

7

47

F

 

-

-

2.6

3

TT3,fT4

+

-

131I

PTC

FVPTC

Azevedo [28]

8

36

M

1.4→1.8 in 11mo

-

HE,IV

1.8

1.5

SHT

+

-

131I

PTC

PTC

Uludag [29]

9

62

F

  

-

 

2

fT3,fT4

+

-

Tc

PTC

PTC

Nishida [30]

10

32

M

 

-

-

4.3

 

fT3,fT4

-

-

Tc

Benign

FVPTC

Kim [31]

11

64

F

 

-

 

6

 

TT3

+

-

131I

 

FTC

Niepomniszcze [32]

12

57

F

  

-

6

 

Highf

+

-

Tc

Nondiagnostic

FTC

Bitterman [33]

13

59

F

  

-

5

 

High

+

 

Tc

 

FTC

Bitterman [33]

14

59

F

 

-

HE,PD,Cal

1.5

1.5

fT3,fT4

+

+

Tc,123I

PTC

PTC

Majima [34]

15

NA

F

   

5

5

fT3,fT4

+

+

Tc

 

PTC

Gozu [35]

16

67

F

   

2.5

3

fT4

+

-

Tc

Benign

Hurthle

Wong [36]

17

39

F

Subjective ↑

 

-

2

 

Nl→SHT

-

- → +

123I

 

PTC

Yaturu [37]

18

36

M

2x size in 5yrs

 

-

2.8

2.3

SHT

-

  

Follicular neoplasm

FVPTC

Logani [38]

19

11

F

 

-

-

 

4

TT3,fT4

+

-

Tc,131I

 

PTC

Mircescu [39]

20

49

F

   

4

3.5

fT4

+

-

123I

 

FTC

Camacho [40]

21

47

M

   

3.5

3.5

fT3

+

 

123I

Suspicious

PTC

Bourasseau [41]

22

36

M

   

2.5

2.5

SHT

  

123I

Nondiagnostic

FTC

Bourasseau [41]

23

56

M

   

5.5

5.5

fT4

+

 

123I

 

FTC

Bourasseau [41]

24

39

F

   

1

1

fT3,fT4

+

 

123I

Suspicious

PTC

Bourasseau [41]

25

33

F

   

3

3

SHT

  

123I

Nondiagnostic

PTC

Bourasseau [41]

26

42

F

4.5→7.4 (no interval given)

-

-

7.4

 

SHT

-

-

123I

Benign

Hurthle

Russo [42]

27

17

F

 

-

HE

2.1

2.1

TT3

-

-

Tc, 123I

 

PTC

Cirillo [43]

28

60

F

  

-

5

6

TT3

+

-

131I

 

Insular

Russo [44]

29

16

F

 

-

 

2

 

TT4

+

-

123I

Colloid

Hurthle

Siddiqui [45]

30

64

F

   

4

 

High

  

123I

 

FTC

Mizukami [46]

31

25

F

 

-

-

4.2

 

TT3,TT4

+

+

131I

 

PTC/FTC

De Rosa [47]

32

72

M

   

2.8

 

TT3,TT4

  

Tc

 

PTC

Ikekubo [48]

33

52

M

   

5

 

TT3

  

Tc

 

PTC

Ikekubo [48]

34

55

F

   

1.6

 

SHT

  

Tc

 

PTC

Ikekubo [48]

35

67

F

 

-

 

3

2.5

TT3,fT4

+

-

123I

Malignant node

PTC

Sandler [49]

36

11

F

 

-

-

3.5

 

TT3

+

-

123I

 

FTC

Nagai [50]

37

45

F

 

-

 

3.5

3

High

+

-

123I

 

FVPTC

Nagai [50]

38

70

F

 

-

 

4

4

fT4

-

-

131I

PTC

PTC

Fukata [51]

39

27

F

 

-

 

3

 

TT4

+

 

131I

 

PTC

Sobel [52]

40

14

M

   

4

 

TT3

+

-

131I

 

PTC

Sobel [52]

41

32

F

 

-

 

2.5

 

TT4

+

 

131I

 

FVPTC

Sobel [52]

42

29

F

 

-

  

1

TT4

+

-

131I

 

PTC

Hoving [53]

43

44

F

  

irregular

2.5

0.3

TT4

+

-

131I

 

PTC

Khan [54]

44

15

F

   

2.5

2.5

TT3

+

-

123I

 

PTC

Hopwood [55]

45

6

F

↑ over 8mo

-

 

5-6x nl

 

High

+

-

131I

 

PTC/FTC

Sussman [56]

46

42

F

4→6 in 4 yrs

  

6

6

High

 

-

  

FTC

Dische [57]

47

71

F

     

fT3,fT4

  

131I

 

FTC

Als [58]

48

62

M

   

8

 

fT3

  

131I

 

FTC

Als [58]

49

62

F

   

7

 

fT3

  

131I

 

FTC

Als [58]

50

71

F

   

4

 

fT3,fT4

  

131I

 

FTC

Als [58]

51

69

F

   

6

 

fT3

  

131I

 

FTC

Als [58]

52

79

F

     

fT3,fT4

  

131I

 

FTC

Als [58]

53

65

M

   

6.5

 

fT3

  

131I

 

FTC

Als [58]

54

56

M

     

fT3

  

131I

 

FVPTC

Als [58]

55

75

M

   

5.5

 

fT3

  

131I

 

FTC

Als [58]

56

77

F

   

4

 

fT3

  

131I

 

PTC

Als [58]

57

71

F

   

6

 

fT3

  

131I

 

FVC

Als [58]

58

63

M

   

6

 

fT3

  

131I

 

FVPTC

Als [58]

59

74

F

   

7

 

fT3,fT4

  

131I

 

FTC

Als [58]

60

68

M

  

HE

6

 

SHT

-

 

Tc

Follicular neoplasm

FTC

Foppiani [12]

61

38

F

  

HE

2.7

 

SHT

  

Tc

Hyperplastic goiter

FTC

Foppiani [12]

62

35

F

 

-

  

>1cm

High

+

 

131I

PTC

PTC

Sahin [13]

63

65

F

 

-

  

>1cm

High

+

 

131I

PTC

PTC

Sahin [13]

64

19

F

   

5

 

TT4,TT3

    

PTC

Lin [59]

65

38

F

 

-

-

 

0.3

TT3

+

 

131I

no malignancy

PTC

Taneri [60]

66

44

F

 

-

Cal

 

1

TT3

+

 

131I

no malignancy

PTC

Taneri [60]

67

56

F

 

-

  

0.8

High

  

131I

 

FTC

Gabriele [14]

68

21

F

 

-

IV

 

1.6

High

  

131I

 

FTC

Gabriele [14]

69

57

F

 

-

-

 

0.7

High

    

PTC

Vaiana [16]

70

58

F

 

-

-

 

3

High

    

PTC

Vaiana [16]

71

51

F

 

-

-

 

0.6

High

    

PTC

Vaiana [16]

72

17

F

 

-

  

1

High

+

   

PTC

Pacini [19]

73

65

F

Subjective ↑

  

5

 

High

+

   

FTC

Terzioglu [18]

74

42

F

     

High

+

   

PTC

Terzioglu [18]

75

35

F

 

-

 

2.2

0.5

High

    

PTC

Zanella [17]

76

70

F

 

-

 

4.1

0.5

High

    

PTC

Zanella [17]

77

35

M

 

-

 

5.4

0.5

High

    

Hurthle

Zanella [17]

  1. Abbreviations: + = yes; - = no; Cal = microcalcifications; FNA = fine needle aspiration; FTC = follicular thyroid carcinoma; FVPTC = follicular variant of papillary thyroid carcinoma; HE = hypoechoic; 123I = Iodine-123; 131I = Iodine-131; IV = internal vascularity; LT4 = levothyroxine; NA = not available; nl = normal; PD = poorly demarcated; PTC = papillary thyroid carcinoma; sx = symptoms; SHT = subclinical hyperthyroidism; fT3 = free triiodothyronine; fT4 = free thyroxine; TT3 = total triiodothyronine; TT4 = total thyroxine; 99mTc = technetium-99m-pertechnetate; TFTs = thyroid function testing; U/S = ultrasound; XRT = external beam radiotherapy.
  2. a High-risk history: ionizing radiation exposure as child/adolescent, prior personal history of thyroid cancer, and family history of thyroid cancer in one or more 1st-degree relatives; as per Cooper et al. [6].
  3. b Suspicious ultrasound: hypoechoic, microcalcifications, increased nodular vascularity, poorly demarcated; as per Cooper et al. [6].
  4. c Nodule size: The largest diameter of the thyroid nodule measured by ultrasonography, or if ultrasound not available, then by palpation.
  5. d Tumor size: The largest diameter of the thyroid nodule measured grossly after surgical resection.
  6. e TFTs: Indicates which thyroid hormone values (total T3, total T4, free T3, and/or free T4) were elevated at time of presentation, as opposed to SHT or euthyroidism. Of note, for many of these cases, no mention of one or more of these four standard thyroid hormone values was included.
  7. f High: Indicates that the patient was biochemically hyperthyroid, though specific thyroid hormone levels were not given.